A day late with this update due to some flu-y unpleasantness yesterday. Seems to have dissipated though so glad about that.
AMRN respected its 50 day MA and descending trend line yesterday. Given this support I established a position at $7.55. A bit smaller than usual – 20%. This means I am fully in the market with a chunk on margin.
ASTX saw some early action based on the news that it had transferred future efforts based on the epigenetics program to its collaborator, GSK. Stock went as high as $2.20 but finished flat.
SPPI had a reasonable day but is slow ahead of earnings. CRIS and DSCO were both quiet.